Objective: Papillary craniopharyngiomas (PCPs) represent a rare histological type of craniopharyngiomas (CPs) usually involving the hypothalamus. This study systematically analyzes the clinical-anatomical correlation between tumor topography and symptoms related to hypothalamic dysfunction in the largest series of PCPs ever gathered. Methods: From 5,346 CP reports published from 1856 to 2021, we selected 350 well-described cases of the squamous-papillary type. Clinical presentation, tumor topography, severity of hypothalamic adhesion, patient outcome, and tumor recurrence were thoroughly analyzed. Results: PCPs predominantly occur in adult (96.3%), male (61.7%) patients presenting with headache (63.4%), visual alterations (56.2%), and psychiatric disturbances (50.4%). Most PCPs are solid (50%), round (72%) lesions that occupy the third ventricle (3V, 94.8%) and show low-risk severity adhesions to the hypothalamus (66.8%). Two major topographical categories can be found: strictly 3V (57.5%), growing above an intact 3V floor, and not-strictly or infundibulo-tuberal (32.9%), expanding at the infundibulum and/or tuber cinereum. The hypothalamic syndrome predominated among strictly 3V PCPs (p < 0.001). Psychiatric symptoms (p < 0.001) and high-risk hypothalamic attachments (p = 0.031) related to unfavorable postoperative outcomes among patients treated from 2006 onwards. The not-strictly 3V topography was identified as the major predictor of high-risk hypothalamic attachments (71.2% correctly predicted), which, along with incomplete tumor removal (p = 0.018), underlies the higher tumor recurrence of this topography (p = 0.001). Conclusions: This systematic review evidences that PCP topography is a major determinant of hypothalamic-related symptoms, type of hypothalamic attachments, and tumor recurrence rate. Accurate preoperative definition of PCP-hypothalamus relationships is essential for the judicious, safe management of these complex lesions.

1.
Louis
DN
,
Perry
A
,
Wesseling
P
,
Brat
DJ
,
Cree
IA
,
Figarella-Branger
D
,
The 2021 WHO classification of Tumors of the Central Nervous System: a summary
.
Neuro Oncol
.
2021 Aug 2
;
23
(
8
):
1231
51
.
2.
Burger
PC
,
Scheithauer
BW
,
Vogel
FS
.
Surgical pathology of the nervous system and its coverings
. 4th ed.
New York
:
Churchill Livingstone
;
2002
. p.
475
82
.
3.
Lopes
M
,
Thapar
K
,
Horvath
E
,
Kovacs
K
.
Neoplasms of the sellar region
. In:
McLendon
RE
,
Rosenblum
MK
,
Bigner
DD
, editors.
Russell and Rubinstein’s pathology of tumors of the nervous system
.
London
:
Hodder Arnold
;
2006
. p.
663
764
. .
4.
Buslei
R
,
Rushing
EG
,
Giangaspero
F
,
Paulus
W
,
Burger
PC
,
Santagata
S
.
Craniopharyngioma
. In:
Louis
DN
,
Ohgaki
H
,
Wiestier
OD
,
Cavenee
W
,
Ellison
DW
,
Figarella-Branger
D
,
, editors.
WHO classification of tumours of the central nervous system
. 4th ed.
Lyon
:
International Agency for Research on Cancer
;
2016
. p.
324
8
.
5.
Pascual
JM
,
Prieto
R
,
Rosdolsky
M
.
Craniopharyngiomas primarily affecting the hypothalamus
. In:
Swaab
DF
,
Lucassen
PJ
,
Kreier
F
,
Buijs
R
,
Salehi
A
, editors.
The human hypothalamus: neuroendocrine disorders
. In: Aminoff MJ, Voller F, Swaab DF, editors. Handbook of clinical neurology. Third series.
Elsevier
;
2021
.
Vol. 181
; p.
75
115
.
6.
Kenning
T
,
Evans
J
.
Fractionated stereotactic radiosurgery alone for the treatment of a papillary craniopharygioma
.
JHN J
.
2012
;
7
(
1
):
1
5
. .
7.
Lee
CC
,
Yang
HC
,
Chen
CJ
,
Hung
YC
,
Wu
HM
,
Shiau
CY
,
Gamma Knife surgery for craniopharyngioma: report on a 20-year experience
.
J Neurosurg
.
2014 Dec
;
121 Suppl
:
167
78
.
8.
Brastianos
PK
,
Taylor-Weiner
A
,
Manley
PE
,
Jones
RT
,
Dias-Santagata
D
,
Thorner
AR
,
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
.
Nat Genet
.
2014 Feb
;
46
(
2
):
161
5
.
9.
Prieto
R
,
Pascual
JM
.
Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview
.
Pituitary
.
2018 Aug
;
21
(
4
):
431
42
. .
10.
Juratli
TA
,
Jones
PS
,
Wang
N
,
Subramanian
M
,
Aylwin
SJB
,
Odia
Y
,
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
.
Cancer
.
2019 Sep 1
;
125
(
17
):
2910
4
.
11.
Pascual
JM
,
Prieto
R
,
Castro-Dufourny
I
,
Carrasco
R
.
Topographic diagnosis of papillary craniopharyngiomas: the need for an accurate MRI-surgical correlation
.
AJNR Am J Neuroradiol
.
2015 Aug
;
36
(
8
):
E55
6
. .
12.
Kleihues
P
,
Burger
PC
,
Scheithauer
BW
.
Histological typing of tumours of the central nervous system
. 2nd ed.
Berlin
:
Springer-Verlag
;
1993
.
13.
Pascual
JM
,
González-Llanos
F
,
Barrios
L
,
Roda
JM
.
Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview
.
Acta Neurochir
.
2004 Aug
;
146
(
8
):
785
802
. .
14.
Pascual
JM
,
Prieto
R
,
Castro-Dufourny
I
,
Carrasco
R
,
Strauss
S
,
Barrios
L
.
Development of intracranial approaches for craniopharyngiomas: an analysis of the first 160 historical procedures
.
Neurosurg Focus
.
2014 Apr
;
36
(
4
):
E13
. .
15.
Pascual
JM
,
Prieto
R
,
Roskolsky
M
,
Strauss
S
,
Castro-Dufourny
I
,
Hofecker
V
,
Cystic tumors of the pituitary infundibulum: seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological craniopharyngioma characterization
.
Pituitary
.
2018 Aug
;
21
(
4
):
393
405
.
16.
Pascual
JM
,
Prieto
R
.
Letter to the editor: craniopharyngiomas in the elderly: the crucial influence of tumor topography on surgical risk assessment
.
Neuroendocrinology
.
2021 Mar
. Epub ahead of print.
17.
Crotty
TB
,
Scheithauer
BW
,
Young
WF
,
Davis
DH
,
Shaw
EG
,
Miller
GM
,
Papillary craniopharyngioma: a clinicopathological study of 48 cases
.
J Neurosurg
.
1995 Aug
;
83
(
2
):
206
14
.
18.
Kahn
EA
,
Gosch
HH
,
Seeger
JF
,
Hicks
SP
.
Forty-five years experience with the craniopharyngiomas
.
Surg Neurol
.
1973 Jan
;
1
(
1
):
5
12
.
19.
Adamson
TE
,
Wiestler
OD
,
Kleihues
P
,
Yaşargil
MG
.
Correlation of clinical and pathological features in surgically treated craniopharyngiomas
.
J Neurosurg
.
1990 Jul
;
73
(
1
):
12
7
. .
20.
Weiner
HL
,
Wisoff
JH
,
Rosenberg
ME
,
Kupersmith
MJ
,
Cohen
H
,
Zagzag
D
,
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome
.
Neurosurgery
.
1994 Dec
;
35
(
6
):
1001
10
; discussion 1010–1.
21.
Duff
J
,
Meyer
FB
,
Ilstrup
DM
,
Laws
ER
 Jr
,
Schleck
CD
,
Scheithauer
BW
.
Long-term outcomes for surgically resected craniopharyngiomas
.
Neurosurgery
.
2000 Feb
;
46
(
2
):
291
5
; discussion 302–5 .
22.
Pekmezci
M
,
Louie
J
,
Gupta
N
,
Bloomer
MM
,
Tihan
T
.
Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985–2005
.
Neurosurgery
.
2010 Nov
;
67
(
5
):
1341
9
. .
23.
Cheng
J
,
Shao
Q
,
Pan
Z
,
You
J
.
Analysis and long-term follow-up of the surgical treatment of children with craniopharyngioma
.
J Craniofac Surg
.
2016 Nov
;
27
(
8
):
e763
6
. .
24.
Mende
KC
,
Kellner
T
,
Petersenn
S
,
Honegger
J
,
Evangelista-Zamora
R
,
Droste
M
,
Clinical situation, therapy, and follow-up of adult craniopharyngioma
.
J Clin Endocrinol Metab
.
2020 Jan
;
105
(
1
):
dgz043
.
25.
Moher
D
,
Liberati
A
,
Tetzlaff
J
,
Altman
DG
.
PRISMA Group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
.
PLoS Med
.
2009 Jul
;
6
(
7
):
e1000097
.
26.
Pascual
JM
,
Prieto
R
,
Carrasco
R
,
Barrios
L
.
Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis
.
J Neurosurg
.
2013 Aug
;
119
(
2
):
381
405
. .
27.
Prieto
R
,
Pascual
JM
,
Barrios
L
.
Optic chiasm distortions caused by craniopharyngiomas: clinical and magnetic resonance imaging correlation and influence on visual outcome
.
World Neurosurg
.
2015 Apr
;
83
(
4
):
500
29
. .
28.
Prieto
R
,
Rosdolsky
M
,
Hofecker
V
,
Barrios
L
,
Pascual
JM
.
Craniopharyngioma treatment: an updated summary of important clinicopathological concepts
.
Expert Rev Endocrinol Metab
.
2020 Jul
;
15
(
4
):
261
82
. .
29.
Castro-Dufourny
I
,
Carrasco
R
,
Prieto
R
,
Pascual
JM
.
Infundibulo-tuberal syndrome: the origins of clinical neuroendocrinology in France
.
Pituitary
.
2015 Dec
;
18
(
6
):
838
43
. .
30.
Prieto
R
,
Pascual
JM
,
Rosdolsky
M
,
Castro-Dufourny
I
,
Carrasco
R
,
Strauss
S
,
Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors
.
Neurosurg Focus
.
2016 Dec
;
41
(
6
):
E13
.
31.
Pascual
JM
,
Prieto
R
,
Castro-Dufourny
I
,
Mongardi
L
,
Roskolsky
M
,
Strauss
S
,
Craniopharyngiomas primarily involving the hypothalamus: a model of neurosurgical lesions to elucidate the neurobiological basis of psychiatric disorders
.
World Neurosurg
.
2018 Dec
;
120
:
e1245
78
.
32.
Prieto
R
,
Pascual
JM
,
Rosdolsky
M
,
Barrios
L
.
Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus
.
World Neurosurg
.
2018 Feb
;
110
:
e404
26
. .
33.
Prieto
R
,
Barrios
L
,
Pascual
JM
.
Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases
.
Neurosurg Rev
.
2021 Aug
. Epub ahead of print. .
34.
Borrill
R
,
Cheesman
E
,
Stivaros
S
,
Kamaly-Asl
ID
,
Gnanalingham
K
,
Kilday
JP
.
Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature
.
Childs Nerv Syst
.
2019 Jan
;
35
(
1
):
169
73
. .
35.
Himes
BT
,
Ruff
MW
,
Van Gompel
JJ
,
Park
SS
,
Galanis
E
,
Kaufmann
TJ
,
Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report
.
J Neurosurg
.
2018 Apr
. Epub ahead of print.
36.
Rokitansy
C
.
Drankheiten der textur. Neubildungen
. In.
Lehrbuch der pathologischen anatomie
.
Wien
:
Wilhem Braumüller
;
1856
. p.
468
.
37.
Giangaspero
F
,
Burger
PC
,
Osborne
DR
,
Stein
RB
.
Suprasellar papillary squamous epithelioma (“papillary craniopharyngioma”)
.
Am J Surg Pathol
.
1984 Jan
;
8
(
1
):
57
64
. .
38.
Karavitaki
N
,
Brufani
C
,
Warner
JT
,
Adams
CB
,
Richards
P
,
Ansorge
O
,
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
.
Clin Endocrinol
.
2005 Apr
;
62
(
4
):
397
409
.
39.
Minamida
Y
,
Mikami
T
,
Hashi
K
,
Houkin
K
.
Surgical management of the recurrence and regrowth of craniopharyngiomas
.
J Neurosurg
.
2005 Aug
;
103
(
2
):
224
32
. .
40.
Gupta
DK
,
Ojha
BK
,
Sarkar
C
,
Mahapatra
AK
,
Mehta
VS
.
Recurrence in craniopharyngiomas: analysis of clinical and histological features
.
J Clin Neurosci
.
2006 May
;
13
(
4
):
438
42
. .
41.
Tena-Suck
ML
,
Salinas-Lara
C
,
Arce-Arellano
RI
,
Rembao-Bojórquez
D
,
Morales-Espinosa
D
,
Sotelo
J
,
Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas
.
Clin Neurol Neurosurg
.
2006 Oct
;
108
(
7
):
661
9
.
42.
Yamada
S
,
Fukuhara
N
,
Oyama
K
,
Takeshita
A
,
Takeuchi
Y
,
Ito
J
,
Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery
.
World Neurosurg
.
2010 Aug–Sep
;
74
(
2–3
):
320
30
.
43.
Zygourakis
CC
,
Kaur
G
,
Kunwar
S
,
McDermott
MW
,
Madden
M
,
Oh
T
,
Modern treatment of 84 newly diagnosed craniopharyngiomas
.
J Clin Neurosci
.
2014 Sep
;
21
(
9
):
1558
66
. .
44.
Morisako
H
,
Goto
T
,
Goto
H
,
Bohoun
CA
,
Tamrakar
S
,
Ohata
K
.
Aggressive surgery based on an anatomical subclassification of craniopharyngiomas
.
Neurosurg Focus
.
2016 Dec
;
41
(
6
):
E10
. .
45.
Pan
J
,
Qi
S
,
Liu
Y
,
Lu
Y
,
Peng
J
,
Zhang
X
,
Growth patterns of craniopharyngiomas: clinical analyisis of 226 patients
.
J Neurosurg Pediatr
.
2016 Apr
;
17
(
4
):
418
33
.
46.
Prieto
R
,
Pascual
JM
,
Subhi-Issa
I
,
Jorquera
M
,
Yus
M
,
Martínez
R
.
Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence
.
World Neurosurg
.
2013 May–Jun
;
79
(
5–6
):
733
49
. .
47.
Hunter
IJ
.
Squamous metaplasia of cells of the anterior pituitary gland
.
J Pathol Bacteriol
.
1955 Jan–Apr
;
69
(
1–2
):
141
5
. .
48.
Larkin
SJ
,
Ansorge
O
.
Pathology and pathogenesis of craniopharyngiomas
.
Pituitary
.
2013 Mar
;
16
(
1
):
9
17
. .
49.
Erdheim
J
.
Über hypophysengangsgeschwülste und hirncholesteatome
.
Sitzungsb Kais Akad Wissen Math Naturw Klin
.
1904
;
113
:
537
726
.
50.
Luse
SA
,
Kernohan
JW
.
Squamous-cell nests of the pituitary gland
.
Cancer
.
1955 May–Jun
;
8
(
3
):
623
8
. .
51.
Tariq
MU
,
Din
NU
,
Ahmad
Z
,
Memon
W
.
Papillary craniopharyngioma: a clinicopathologic study of a rare entity from a major tertiary care center in Pakistan
.
Neurol India
.
2017 May–Jun
;
65
(
3
):
570
6
. .
52.
Harrison
MJ
,
Morgello
S
,
Post
KD
.
Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives?
J Neurosurg
.
1994 Jun
;
80
(
6
):
1018
25
. .
53.
Zada
G
,
Lin
N
,
Ojerholm
E
,
Ramkissoon
S
,
Laws
ER
.
Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships
.
Neurosurg Focus
.
2010 Apr
;
28
(
4
):
E4
. .
54.
Schlaffer
SM
,
Buchfelder
M
,
Stoehr
R
,
Buslei
R
,
Hölsken
A
.
Rathke’s cleft cyst as origin of a pediatric papillary craniopharyngioma
.
Front Genet
.
2018 Feb
;
9
:
49
. .
55.
Magaki
S
,
Raghavan
R
,
Minasian
T
,
de los Reyes
K
,
Kelly
T
,
Farzin-Gohar
S
,
Papillary craniopharyngioma in a young child: the importance of BRAF mutational testing
.
Can J Neurol Sci
.
2020 Jan
;
47
(
1
):
148
50
.
56.
Szeifert
GT
,
Sipos
L
,
Horváth
M
,
Sarker
MH
,
Major
O
,
Salomváry
B
,
Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases
.
Acta Neurochir
.
1993
;
124
(
2–4
):
139
43
.
57.
Fahlbusch
R
,
Honegger
J
,
Paulus
W
,
Huk
W
,
Buchfelder
M
.
Surgical treatment of craniopharyngiomas: experience with 168 patients
.
J Neurosurg
.
1999 Feb
;
90
(
2
):
237
50
. .
58.
Tavangar
SM
,
Larijani
B
,
Mahta
A
,
Hosseini
SM
,
Mehrazine
M
,
Bandarian
F
.
Craniopharyngioma: a clinicopathological study of 141 cases
.
Endocr Pathol
.
Winter 2004
;
15
(
4
):
339
44
. .
59.
Agozzino
L
,
Ferraraccio
F
,
Accardo
M
,
Esposito
S
,
Agozzino
M
,
Cuccurullo
L
.
Morphological and ultrastructural findings of prognostic impact in craniopharyngiomas
.
Ultrastruct Pathol
.
2006 May–Jun
;
30
(
3
):
143
50
. .
60.
Lopez-Serna
R
,
Gómez-Amador
JL
,
Barges-Coll
J
,
Nathal-Vera
E
,
Revuelta-Gutiérrez
R
,
Alonso-Vanegas
M
,
Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience
.
Arch Med Res
.
2012 Jul
;
43
(
5
):
347
55
.
61.
Shi
X
,
Zhou
Z
,
Wu
B
,
Zhang
Y
,
Qian
H
,
Sun
Y
,
Outcome of radical surgical resection for craniopharyngioma with hypothalamic preservation: a single-center, retrospective study of 1054 patients
.
World Neurosurg
.
2017 Jun
;
102
:
167
80
.
62.
Pascual
JM
,
Prieto
R
.
Harvey Cushing’s craniopharyngioma treatment. Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor
.
J Neurosurg
.
2018 Oct
;
131
(
3
):
949
63
.
63.
Momin
AA
,
Recinos
MA
,
Cioffi
G
,
Patil
N
,
Soni
P
,
Almeida
JP
,
Descriptive epidemiology of craniopharyngiomas in the United States
.
Pituitary
.
2021 Aug
;
24
(
4
):
517
22
.
64.
Zhang
YQ
,
Wang
CC
,
Ma
ZY
.
Pediatric craniopharyngiomas: clinicomorphological study of 189 cases
.
Pediatr Neurosurg
.
2002 Feb
;
36
(
2
):
80
4
. .
65.
Müller
HL
,
Merchant
TE
,
Warmuth-Metz
M
,
Martinez-Barbera
JP
,
Puget
S
.
Craniopharyngioma
.
Nat Rev Dis Primers
.
2019 Nov 7
;
5
(
1
):
75
.
66.
Prieto
R
,
Pascual
JM
,
Barrios
L
.
Letter: a clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas
.
Neurosurgery
.
2019 Nov
;
85
(
5
):
E962
5
. .
67.
Pan
J
,
Qi
S
,
Lu
Y
,
Fan
J
,
Zhang
X
,
Zhou
J
,
Intraventricular craniopharyngioma: morphological analysis and outcome evaluation of 17 cases
.
Acta Neurochir
.
2011 Apr
;
153
(
4
):
773
84
.
68.
Pascual
JM
,
Carrasco
R
,
Prieto
R
,
Gonzalez-Llanos
F
,
Alvarez
F
,
Roda
JM
.
Craniopharyngioma classification
.
J Neurosurg
.
2008 Dec
;
109
(
6
):
1180
3
. .
69.
Apra
C
,
Enachescu
C
,
Lapras
V
,
Raverot
G
,
Jouanneau
E
.
Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement?
World Neurosurg
.
2019 Sep
;
129
:
e803
11
. .
70.
Prieto
R
,
Castro-Dufourny
I
,
Carrasco
R
,
Barrios
L
,
Pascual
JM
.
Craniopharyngioma recurrence: the impact of tumor topography
.
J Neurosurg
.
2016 Oct
;
125
(
4
):
1043
9
. .
71.
Eldevik
OP
,
Blaivas
M
,
Gabrielsen
TO
,
Hald
JK
,
Chandler
WF
.
Craniopharyngioma: radiologic and histologic findings and recurrence
.
AJNR Am J Neuroradiol
.
1996 Sep
;
17
(
8
):
1427
39
.
72.
Sartoretti-Schefer
S
,
Wichmann
W
,
Aguzzi
A
,
Valavanis
A
.
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas
.
AJNR Am J Neuroradiol
.
1997 Jan
;
18
(
1
):
77
87
.
73.
Steno
J
,
Malácek
M
,
Bízik
I
.
Tumor-third ventricular relationships in supradiaphragmatic craniopharyngiomas: correlation of morphological, magnetic resonance imaging, and operative findings
.
Neurosurgery
.
2004 May
;
54
(
5
):
1051
60
. .
74.
Lee
JH
,
Wu
CC
,
Wu
HM
,
Hung
SC
,
Lirng
JF
,
Luo
CB
,
Pretreatment diagnosis of suprasellar papillary craniopharyngioma and germ cell tumors of adult patients
.
AJNR Am J Neuroradiol
.
2015 Mar
;
36
(
3
):
508
17
.
75.
Fujio
S
,
Juratli
TA
,
Arita
K
,
Hirano
H
,
Nagano
Y
,
Takajo
T
,
A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas
.
Neurosurgery
.
2019 Aug
;
85
(
2
):
204
10
.
76.
Yue
Q
,
Yu
Y
,
Shi
Z
,
Wang
Y
,
Zhu
W
,
Du
Z
,
Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features
.
J Neurosurg
.
2018 Jul
;
129
(
1
):
27
34
.
77.
Prieto
R
,
Pascual
JM
.
Craniopharyngioma diagnosis: a rationale for accurate MRI assessment of tumor topography and adhesion to the hypothalamus
. In:
Joanneau
E
,
Raverot
G
, editors.
Adult craniopharyngiomas. Differences and lessons from paediatrics
.
Cham, Switzerland
:
Springer
;
2020
. p.
55
77
. .
78.
Pascual
JM
,
Prieto
R
,
Carrasco
R
.
Infundibulo-tuberal or not strictly intraventricular craniopharyngioma: evidence for a major topographical category
.
Acta Neurochir
.
2011 Dec
;
153
(
12
):
2403
26
. .
79.
Prieto
R
,
Pascual
JM
,
Barrios
L
.
Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images
.
AJNR Am J Neuroradiol
.
2017 Nov
;
38
(
11
):
2073
80
. .
80.
Fan
J
,
Liu
Y
,
Pan
J
,
Peng
Y
,
Peng
J
,
Bao
Y
,
Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients
.
J Neurosurg
.
2021
. Epub ahead of print.
81.
Petito
CK
,
DeGirolami
U
,
Earle
KM
.
Craniopharyngiomas: a clinical and pathological review
.
Cancer
.
1976 Apr
;
37
(
4
):
1944
52
. .
82.
Du
C
,
Feng
CY
,
Yuan
XR
,
Liu
Q
,
Peng
ZF
,
Jiang
XJ
,
Microsurgical management of craniopharyngiomas via a unilateral subfrontal approach: a retrospective study of 177 continuous cases
.
World Neurosurg
.
2016 Jun
;
90
:
454
68
.
83.
Yu
T
,
Sun
X
,
Ren
X
,
Cui
X
,
Wang
J
,
Lin
S
.
Intraventricular craniopharyngiomas: surgical management and outcome analyses in 24 cases
.
World Neurosurg
.
2014 Dec
;
82
(
6
):
1209
15
. .
84.
Forbes
JA
,
Ordóñez-Rubiano
EG
,
Tomasiewicz
HC
,
Banu
MA
,
Younus
I
,
Dobri
GA
,
Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results
.
J Neurosurg
.
2018
. Epub ahead of print.
85.
Pascual
JM
,
Prieto
R
,
Navas
M
,
Carrasco
R
.
Conquest of third ventricle craniopharyngiomas
.
J Neurosurg
.
2010 May
;
112
(
5
):
1156
61
. .
86.
Cavallo
LM
,
Frank
G
,
Cappabianca
P
,
Solari
D
,
Mazzatenta
D
,
Villa
A
,
The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients
.
J Neurosurg
.
2014 Jul
;
121
(
1
):
100
13
.
87.
Pascual
JM
,
Prieto
R
,
Dufourny
IC
,
Simoes
RG
,
Carrasco
R
.
Hypothalamus-referenced classification for craniopharyngiomas: evidence provided by the endoscopic endonasal approach
.
Neurosurg Rev
.
2013 Apr
;
36
(
2
):
337
9
. .
88.
Honegger
J
,
Grabenbauer
GG
,
Paulus
W
,
Fahlbusch
R
.
Regression of a large solid papillary craniopharyngioma following fractionated external radiotherapy
.
J Neurooncol
.
1999 Feb
;
41
(
3
):
261
6
. .
89.
Chung
WY
,
Pan
DH
,
Shiau
CY
,
Guo
WY
,
Wang
LW
.
Gamma knife radiosurgery for craniopharyngiomas
.
J Neurosurg
.
2000 Dec
;
93
(
Suppl 3
):
47
56
. .
90.
Ulfarsson
E
,
Lindquist
C
,
Roberts
M
,
Rähn
T
,
Lindquist
M
,
Thorén
M
,
Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients
.
J Neurosurg
.
2002 Dec
;
97
(
5 Suppl
):
613
22
.
91.
Terada
A
,
Iwai
K
,
Yoshimura
M
,
Yamanaka
K
.
[Surgical resection and boost gamma knife radiosurgery for the third ventricular craniopharyngiomas]
.
J Endocrino Soc Japan
.
2012 Aug
;
88
:
29
31
. Japanese.
92.
Gopalan
R
,
Dassoulas
K
,
Rainey
J
,
Sherman
JH
,
Sheehan
JP
.
Evaluation of the role of Gamma Knife surgery in the treatment of craniopharyngiomas
.
Neurosurg Focus
.
2008
;
24
(
5
):
E5
. .
93.
Schweizer
L
,
Capper
D
,
Hölsken
A
,
Fahlbusch
R
,
Flitsch
J
,
Buchfelder
M
,
BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke’s cleft cysts
.
Neuropathol Appl Neurobiol
.
2015 Oct
;
41
(
6
):
733
43
.
94.
ClinicalTrials.gov Identifier: NCT03224767 [Internet] phase II trial of BRAF/MEK inhibitors in papillary craniopharyngiomas. Available from: clinicaltrials.gov/ct2/show/study/NCT03224767.
95.
Petito
CK
.
Craniopharyngioma: prognostic importance of histologic features
.
AJNR Am J Neuroradiol
.
1996 Sep
;
17
(
8
):
1441
2
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.